Yeh Y H, Huang M H, Yang J C, Mo L R, Lin J, Yueh S K
Department of Medicine, Surgery, and Radiology, Show-Chwan Memorial Hospital, Changhua, Taiwan, R.O.C..
Gastrointest Endosc. 1995 Jul;42(1):13-8. doi: 10.1016/s0016-5107(95)70236-9.
Intrahepatic stones are characterized by high treatment failure and recurrence rates. In the past, surgery played a major role in the management of this disease, but surgical intervention may not be feasible in previously operated patients or those classified as poor surgical risks. The development of percutaneous trans-hepatic cholangioscopy and lithotripsy has played an important role in the treatment of these patients.
We reviewed our results in 165 patients with intrahepatic stones treated by percutaneous trans-hepatic cholangioscopy and lithotripsy in the past 12 years.
The rate of complete stone removal was 80% (132 cases) and the rate of recurrent biliary stones after a mean 58 month follow-up interval was 32.6% (43 of 132 cases). There were 2 deaths during the treatment period and 10 deaths during follow-up.
Percutaneous trans-hepatic cholangioscopy and lithotripsy are good alternatives in treating primary intrahepatic stones, especially for those patients unsuitable for surgery.
肝内结石的特点是治疗失败率和复发率高。过去，手术在这种疾病的治疗中起主要作用，但对于既往接受过手术的患者或被归类为手术风险较高的患者，手术干预可能不可行。经皮肝穿刺胆管镜检查和碎石术的发展在这些患者的治疗中发挥了重要作用。
我们回顾了过去12年中通过经皮肝穿刺胆管镜检查和碎石术治疗的165例肝内结石患者的结果。
结石完全清除率为80%（132例），平均随访58个月后胆石复发率为32.6%（132例中的43例）。治疗期间有2例死亡，随访期间有10例死亡。
经皮肝穿刺胆管镜检查和碎石术是治疗原发性肝内结石的良好替代方法，特别是对于那些不适合手术的患者。
